AbbVie and its subsidiary Allergan have had a long run of unchallenged success in the market with cosmetic and therapeutic treatment Botox. Now, the companies have extended their dominance to the ...
July 21 (Reuters) - A Delaware federal jury said on Friday that Revance Therapeutics owes AbbVie's (ABBV.N), opens new tab Allergan Inc $56 million after finding that Revance's anti-wrinkle medication ...
NORTH CHICAGO, Ill., Oct. 6, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced positive topline results from the Phase 2 ELATE trial evaluating the safety and efficacy of onabotulinumtoxinA (BOTOX®) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results